Cargando…
Cannabinoids and Chronic Liver Diseases
Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis are the main causes of morbidity and mortality related to chronic liver diseases (CLDs) worldwide. New therapeutic approaches to prevent or reverse these liver disorders are thus emerging. Although the...
Autores principales: | Mboumba Bouassa, Ralph-Sydney, Sebastiani, Giada, Di Marzo, Vincenzo, Jenabian, Mohammad-Ali, Costiniuk, Cecilia T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408890/ https://www.ncbi.nlm.nih.gov/pubmed/36012687 http://dx.doi.org/10.3390/ijms23169423 |
Ejemplares similares
-
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2023) -
Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022) -
High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study
por: Mossoro-Kpinde, Christian Diamant, et al.
Publicado: (2017) -
Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2020) -
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
por: Costiniuk, Cecilia T., et al.
Publicado: (2020)